↓ Skip to main content

Using four decades of FDA orphan drug designations to describe trends in rare disease drug development: substantial growth seen in development of drugs for rare oncologic, neurologic, and pediatric-ons…

Overview of attention for article published in Orphanet Journal of Rare Diseases, June 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#20 of 3,143)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
24 news outlets
blogs
1 blog
twitter
5 X users

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
77 Mendeley